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Background
In European countries, the lifetime prevalence of general-
ised anxiety disorder (GAD) varies from 5 to 10% [1-5]. Un-
controllable worrying as a primary symptom of GAD
constitutes a maladaptive cognitive strategy to avoid experi-
encing anxiety [6,7] and emotional states in general [8,9].
Individuals with GAD show deficits in detecting and regu-
lating emotional states, which may accelerate a positive
feedback circuit between general stress symptoms and
pathological worrying [10-12]. Finally, experiential avoid-
ance may lead to a restriction in proactive behaviours as in-
dividuals become focused on avoiding events and situations
rather than pursuing activities that are consistent with their
personal values [13,14], which may be related to the hyper-
sensitivity of the Behavioural Inhibition System seen in in-
dividuals with GAD [15].
Bonafide psychotherapy is an effective treatment for GAD
compared to no-treatment and treatment as usual [16-18],
but also more generally for individuals that suffers from
anxiety and depression [19]. For cognitive-behavioural
therapy (CBT), there are a number of treatment manuals/
protocols, e.g. psycho education, relaxation techniques,
cognitive restructuring of (meta-) cognitions, (imagery-)
exposure, and in vivo confrontation, that primarily reference
standard techniques to correct and compensate GAD
symptoms [20-24]. In addition, strengths-oriented strategies
aim to capitalise on the patient’s pre-existing resources, such
as the patient’s individual and interpersonal abilities and
readiness. Such strategies, e.g. acceptance strategies [25],
motivational interviewing [26], and well-being therapy
[27] and, more generally, solution-focused interventions
[28], positive interventions [29], resilience-focused inter-
ventions [30] and resource-oriented approaches [31-34],
have recently been discussed for GAD treatment. Such
strengths-oriented tools, however, may be based on more
general counselling and consulting psychology principles,
such as making hope explicit [35,36] or understanding
the client’s functional behaviours [37-39].
The separation into compensation- and capitalisation-
oriented strategies probably a false dichotomy, and psycho-
therapy (socratic) dialogues often simultaneously respond
to the participants’ targeted weaknesses and strengths in
general [40-43] but also to GAD more specifically [44].
Psychotherapy dialogues can be seen as a highly interactive
and responsive treatment through which therapists and pa-
tients work together to achieve well-specified treatment
goals that take into consideration the patients’ entire living
environment, including strengths and weaknesses [45-47].
Rather than creating increasing numbers of new over-
all treatment-packets within a medical meta-model, an
additional approach to investigating clinical research
designs may be to increase the understanding of already
effective psychotherapies [45,48-50]. Moreover, psycho-
therapy research is moving from legitimation- and
competition-oriented investigations to more comprehension-
oriented process-outcome based research [51]. Treat-
ment manuals and protocols allow a relatively high
degree of freedom for the way therapists implement the
overall treatment manuals. There is a systematic lack of
knowledge on how therapists should customise these
overall protocols [31,52,53]. The present study experi-
mentally examined three ways of conducting a
cognitive-behavioural therapy (CBT) protocol and their
relation to the therapists’ protocol adherence and treat-
ment efficacy.
Aims of the trial
This trial will investigate three different methods of
customising bonafide psychotherapy based on a well-
introduced CBT-protocol by Zinbarg, Craske and
Barlow [24] using dyadic peer-tutoring methodology
(primings). The participants will be randomly assigned
to three priming conditions: (a) adherence priming;
(b) resource priming or (c) supportive resource prim-
ing [32,39].
The main research questions are as follows:
(1) In-session outcomes. Using videotapes, observer-
based video analyses will be conducted: (a) Do
the resource priming conditions show comparable
observer-based adherence of the therapist in com-
parison to the adherence priming condition [54]?
(b) Do the resource priming conditions result in
more resource-activating micro-interventions than
the adherence priming condition [55]? (c) Are the
in-session processes predictors and mediators of
session and therapy outcomes [43]?
(2) Post-session outcomes. Are there differences in the
post-session outcomes for the 3 different priming
conditions? Furthermore, are the post-session
outcomes also symptom change predictors and
mediators of therapy outcome [56]?
(3) Treatment outcomes. Do the resource priming
conditions have comparable efficacy on GAD
outcomes, general outcomes and dropout rates in
comparison to the adherence priming condition?
Methods/design
This study is a randomised controlled trial with three active
treatment arms. This trial will be conducted at the Swiss
psychotherapy outpatient clinic in the Department of
Psychology at the University of Zürich. Figure 1 depicts the
3 × 4 design with one between-subject factor (resource
priming, supportive resource priming, or problem priming)
and one within-subject factor (time: pre, mid, post, or
follow-up).
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Participants
Inclusion/exclusion criteria
Participants will be included in the study if they: (a) are
18 years of age or older; (b) agree to the informed consent,
(c) have sufficient knowledge of German; and (d) and fulfil
the diagnostic criteria of GAD DSM-IV. Participants will be
excluded for the following reasons: (a) they have a score of
2 or higher on the suicide item of the BDI and/or are found
to have active suicidal plans during the diagnostic screening
interview, (b) they are currently taking a psychotic or bipo-
lar disorder medication, or (c) they are currently receiving
treatment from a professional psychotherapist. Prescribed
medications for anxiety or depressive disorders do not lead
to exclusion from the study, if the dosage has remained
constant for at least one month. The presence of comorbid-
ities does not result in exclusion from the study, if GAD is
in the foreground according to the severity rating of the
Diagnostic Interview for DSM-diagnoses.
Recruitment
Participants will be recruited by means of advertise-
ments in newspapers and through internet forums.
High-circulation newspapers are delivered for free
through the Swiss public transport system. Individuals
interested in participating in the study will contact the
study office via SMS, e-mail or phone. Positively
screened patients will be invited for an intake assess-
ment to determine whether they will be included or ex-
cluded using a standardised interview. Participants that
are not screened positively will be informed of more ap-
propriate treatments via a phone call or, if requested, a
face-to-face contact.
Randomisation and treatment allocation
After meeting the inclusion criteria, patients will be ran-
domly assigned to one of the three conditions (adher-
ence priming, resource priming, or supportive resource
priming). Treatment allocation is performed using an
online application for full randomisation. In this way, we
aim to ensure that the trial arms are balanced with re-
spect to the patients’ baseline characteristics. Random-
isation will be conducted by two independent research
assistants. Because all patients will be treated using the
same CBT-manual, patients are blinded to their treat-
ment allocation and are not informed about the random-
isation procedure.
GAD treatment protocol
CBT-manual by Zinbarg, Craske and Barlow (MAW-
packet) [24]: CBT for GAD typically consists of psycho-
education of generalised anxiety disorder, relaxation
training (RT), cognitive restructuring (CR) and some in-
vivo situational exposure for patients with overt behav-
ioural avoidance [20,22]. Furthermore, imagery exposure
as a GAD-specific form of in-sensu exposition will be
applied to reduce experiential avoidance. The manua-
lized therapy follows a usual treatment format of 14 50-
minute sessions and a booster session after 6 months
(15 sessions in total).
Tandem peer-tutoring (priming)
To investigate various methods of conducting a standar-
dised CBT-protocol, all therapists are tutored in peer
dyads (tandem peer-tutoring). Immediately before ses-
sions 1 to 5, the therapists are required to contact the
Screening of GAD-diagnosis
Participants with a GAD-diagnosis based on the DSM-V criteria (N = 60)
Randomisation
n = 20 n = 20 n = 20
Manualized CBT protocol for 
GAD 
Adherence priming 
Manualized CBT protocol for 
GAD 
Resource priming
Manualized CBT protocol for 
GAD 
Supportive resource priming
mid (6-week) & post (14-week 
assessment
mid (6-week) & post (14-week 
assessment
mid (6-week) & post (14-week 
assessment
6-month follow up 6-month follow up 6-month follow up
Figure 1 Flow chart of the study design.
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tandem-partner face-to-face or on the phone to discuss
the upcoming session in a 5 to 10 minute brief conversa-
tion (primings; for a comparable procedure see Flückiger
and Grosse Holtforth [32]). There are three tandem
peer-tutoring conditions:
(1) Adherence priming: Immediately before sessions 1
to 5, a therapist conducts five-minute conversation
about how to implement the disorder-specific inter-
ventions that are described in the treatment proto-
col. These communications are focused on the
therapist’s understanding of the patients GAD and
any related comorbidities and how those issues can
be addressed in the prescriptive treatment protocol.
(2) Resource priming: Immediately before sessions 1 to 5,
a therapist conducts a five-minute conversation with
the participant about how to implement strengths-
based micro-interventions in the upcoming session.
Strengths-based micro-interventions allow therapists
to focus on a patient’s pre-existing strengths and
abilities, subtle changes and improvements to those
strengths and abilities during therapy (potential
resources), and motivational preparedness, readiness
and goals (motivational resources) [39,57].
(3) Supportive resource priming: The supportive
resource priming condition uses the same protocol
as the resource priming condition (5 brief tandem
peer-tutorings). The only difference in the proced-
ure is that the therapists are allowed to integrate a
helpful significant person from the patients entou-
rage (such as a partner or best friend) during ses-
sions 1 and 7 to encourage them to support the
patient in adhering to their treatment plan (active
integration of interpersonal resources). However,
the integration of a significant person does not
affect the CBT-treatment protocol.
Therapists
Twelve advanced trainees with at least 2 years post-
graduate training will be recruited from local psy-
chotherapy-training centres. The majority of those
therapists have experience as study therapists in a prior
randomised controlled trial (ClinicalTrials.gov Identifier:
NCT01012856). All of the therapists will participate in an
initial 16-hour workshop presented by the (co-)developer
of the treatment manual (Zinbarg) [24]. In addition to the
peer-tutoring (primings), the therapists will be regularly su-
pervised in small groups on a 14-day basis. The supervision
is conducted in mixed groups for all three priming condi-
tions. All of the supervisors also participate in the initial
16-hour workshop. To respect and coordinate the thera-
pists’ preferences (e.g., preferences in working days and
time schedules) they will be assigned in a joint face-to-face
session at the beginning of the study. All of the therapists
will give verbal and written consent for their selected peer-
tutoring partner and priming condition. To control for
potential effects of particular therapists, we will investigate
the therapists’ self-reported interpersonal strengths and
problems, their attachment quality and their therapeutic
attitudes along with their allegiance to the underlying CBT-
protocol.
Assessments
For an overview of the assessments see Table 1. At intake,
GAD-diagnosis and its core symptomatology will be identi-
fied according to the structured interview section for GAD
(DIPS; [58]). Furthermore, GAD-criteria are assessed using
self-reports. The individual worries are identified using the
Penn State Worry Questionnaire (PSWQ; [59,60]) and the
Worry Domain Questionnaire (WDQ; [60,61]). Mental dis-
orders on Axis I and II are assessed using face-to-face diag-
nostic interviews (Strukturiertes Klinisches Interview für
DSM, SKID-I/II; [62]).
The PSWQ, Beck Anxiety Inventory (BAI; [63,64]) and
the State-Trait Anxiety (STAI; [65,66]) questionnaire will
used to measure GAD-outcomes. Premature termination
from the trial, interpersonal problems and strengths inven-
tories, general symptom severity, the behavioural inhibition
and activation scale, as well as the resource potential
questionnaire will be used to measure general outcomes
(see Table 1). The outcome measures are taken at intake,
directly after session 6 (end of primings), session 14 (post-
assessment), and at the 6-month follow-up.
The following process measures are examined: (a) Post-
session reports: alliance [78,79], post-session outcomes [80]
and symptom change are conducted based on a session-by-
session assessment from session 1 to 15 and (b) In-session
processes: using the recorded videotapes, adherence ratings
for the CBT-program [54], the Resource-Oriented Micro-
process Analysis (ROMA-P/T; [55]) and the level of expli-
cation scale by Sachse [81] are conducted at sessions 2, 5
and 8.
Study from the participants view
After contacting the study administration, the informa-
tion given to the participants will contain a precise de-
scription of the inclusion and exclusion criteria, the
structure of the treatment manual as well as the data
collection procedure, including the procedure for the
videorecordings (Figure 2). Confidentiality of the col-
lected data will be confirmed. Voluntariness of participa-
tion will be emphasised by explaining the opportunity to
terminate the treatment at every timepoint during treat-
ment and the opportunity to cancel the use of any data
collected. Furthermore, an insurance policy for possible
negative outcomes resulting from participation in clin-
ical trials will be contracted.
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Statistical analysis
To handle the hierarchical data structures (sessions at
level 1 nested within patients at level 2 and therapists at,
level 3), a hierarchical linear model (HLM) with time as
a within-groups factor and the treatment condition as a
between-groups factor will be used for the main research
questions [85]. The analyses will be conducted on the
intention-to-treat sample as well as on the completer
sample. To investigate if patients and therapists have
effects on the therapy outcomes, the patients’ and
therapists’ pre-treatment characteristics will be investi-
gated as outcome predictors at levels 2 and 3.
Sample size
Based on a power analysis with G*Power [86], the opti-
mal sample size with an Alpha-error of 5%, a Beta-error
of 80% and a correlation coefficient for the repeated
assessments of of r = .30 is 60 participants, i.e., 20 partic-
ipants in each priming condition.
Table 1 Schedule of measures
Measures Measurement waves
Ass. Pre Sess-by-Sess Mid Post FU
Eligibility
Structured Interview for DSM (SCID) [62] +
GAD-section of the (F-DIPS) [58] +
GAD-criteria self-report [62] +
WDQ [60,61] +
GAD-outcomes
Beck Anxiety Inventory (BAI) [63,64] + 1-15 + + +
Penn State Worry Questionnaire (PSWQ) [59,60] + + + + +
State –Trait Anxiety (STAI) [65,66] + + + +
General-outcomes
Premature termination 1-15
Beck Depression Inventory II (BDI-II) [67,68] + + + + +
Brief Symptom Inventory (BSI) [69,70] + + + +
BIS/BAS scales [71,72] + + + +
Inventory of Interpersonal Problems (IIP-64) [73,74] + + + +
Inventory of Interpersonal Strengths (IIS-64) [75,76] + + + +
Resource potential questionnaire (RES) [75,77] + + + +
Self-report process-measures
Working Alliance Inventory - Patient (WAI-P) [78,79] 1-15
Working Alliance Inventory – Therapist (WAI-T) [78,79] 1-15
Bern Post-Session Report – Patient (BPSR-P) [80] 1-15
Bern Post-Session Report – Therapist (BPSR-T) [80] 1-15
Video observer ratings
Adherence rating 2,5,8,11
Resource-oriented Microprocess Analysis – Patient (ROMA-P) [55] 2,5,8,11
Resource-oriented Microprocess Analysis – Therapist (ROMA-T) [55] 2,5,8,11
Level of explication [81] 2,5,8,11
Therapists’ measures
Inventory of Interpersonal Problems (IIP-64) [73,74] +1
Inventory of Interpersonal Strengths (IIS-64) [75,76] +1
Measure of Attachment Quality (MAQ) [82,83] +1
Therapists’ allegiance self-report +1
Therapeutic Attitude Scale (TASC), therapeutic style section [84] +2
1At the beginning of the study, 2At the overall end of the treatment.
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Ethical review
This study protocol is approved by the Ethical Committee
of Canton Zurich (KEK 2011–0475) and the Ethical
Committee of the Philosophical Faculty of University of
Zurich (PhiF-EK_20.1.2012).
Discussion
Bonafide psychotherapy is an effective treatment for indi-
viduals who suffer from GAD and its comorbidities in com-
parison to no-treatment and treatment as usual [16,17,18].
Rather than creating increasing numbers of new overall
treatment-packets within a medical meta-model, an
additional approach may be to increase the understanding
of already effective psychotherapies [45,48-50]. The
psychotherapy field is moving from legitimation and com-
petition focused research to a more comprehension-
oriented process-outcome research methodology [47,51].
Treatment manuals and protocols allow a relatively high
degree of freedom for the way therapists implement the
treatment protocols. The present design experimentally ex-
amines the therapists’ within-protocol variability and its re-
lation to treatment outcome. More specifically, three
methods of conducting the same treatment protocol are
compared to each other using tandem peer-tutoring meth-
odology (resource priming, supportive resource priming,
and adherence priming).
The hierarchical structure of the design allows the
simultaneous examination of the patients’ contributions
and the therapists’ contributions. In contrast to double
blinded medication trials, therapists’ and patients’ are in-
formed and actively involved in the psychotherapeutic
treatment plans. This involvement is not a bias that has
to be eliminated and it might be well an active ingredi-
ent of a successful psychotherapy that the therapists’ and
patients’ take a proactive, responsive role in the treat-
ment [37,87]. The present design allows for the experi-
mental investigation of some potentially meaningful
aspects of this proactive variability.
Bias minimization
Participants
Patients will be randomly assigned to conditions in order
to reduce potential biases of participant characteristics.
The inclusion and exclusion criteria allow for a relatively
homogeneous group of individuals; the primary GAD
diagnoses, comorbidities with substance use disorders
and severity of depression along with age, sex and gen-
der will be tested as potential confounders.
In traditional psychotherapy trials, where two or more
treatments protocols are compared to each other, the
patients’ are informed about the various randomised
treatment conditions of the active treatments (e.g., psy-
chotherapy vs. waiting list). In the present trial, the pa-
tients’ are treated with the same treatment protocol, and,
thus the randomisation procedure essentially does not
affect the overall treatment plan. Referring to the pre-
existing standards, the patients can be blinded to the
randomised therapist conditions in order to reduce po-
tential biases from the outcome expectations of the
patients.
Therapists
A potential bias due to allegiances of the therapists is a con-
cern, especially in human treatments where inductions of
outcome expectations can be problematic. To minimise this
potential bias, therapists will be allocated to the peer-
tutoring partners based on common consent. Furthermore,
they will be supervised in mixed groups, where the priming
condition plays no explicit role and the supervisors are
advised to focus on therapist skills independent of the
underlying priming conditions. Nonetheless, because the
therapists are informed about the treatment protocol, the
allegiances of the therapists to specific CBT protocols will
be declared and considered in the statistical analyses.
Keeping the above mentioned strengths and limitations
of the present design in mind, the proposed trial addresses
the clinically relevant question of how to customise a
Figure 2 Study from the participant’s point of view.
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bonafide psychotherapy using tandem peer-tutoring meth-
odology (three priming conditions). Through the develop-
ment and testing of the proposed priming procedures, the
study could potentially define levels of adherence for con-
ducting an overall treatment protocol more appropriately
[52,88].
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